ArticlebioRxiv : the preprint server for biology2024
PROTAC-mediated dual degradation of BCL-xL and BCL-2 is a highly effective therapeutic strategy in small-cell lung cancer.
Sajid Khan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.